======= IPO9 ======= == Gene Information == * **Official Symbol**: IPO9 * **Official Name**: importin 9 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55705|55705]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96P70|Q96P70]] * **Interactions**: [[https://thebiogrid.org/search.php?search=IPO9&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IPO9|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620893|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |IBN N| |nuclear import signal receptor activity| |Ran GTPase binding| |protein import into nucleus| |import into nucleus| |histone binding| |protein import| |protein localization to nucleus| |nuclear envelope| |nucleocytoplasmic transport| |nuclear transport| |establishment of protein localization to organelle| |protein localization to organelle| |intracellular protein transport| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |establishment of localization in cell| |nitrogen compound transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-2.62| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|-2.44| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-2.16| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|-2.15| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-2.03| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-2.02| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-1.89| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.88| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-1.86| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-1.86| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-1.81| |[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|-1.79| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.79| |[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|-1.78| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.72| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-1.7| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|2.55| |[[:results:exp504|MK2206 4μM R08 exp504]]|2.74| ^Gene^Correlation^ |[[:human genes:e:elmsan1|ELMSAN1]]|0.408| |[[:human genes:r:rpp21|RPP21]]|0.407| Global Fraction of Cell Lines Where Essential: 367/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|12/28| |blood|13/28| |bone|9/25| |breast|20/33| |central nervous system|23/56| |cervix|1/4| |colorectal|7/17| |esophagus|7/13| |fibroblast|1/1| |gastric|10/15| |kidney|14/21| |liver|9/20| |lung|41/75| |lymphocyte|5/14| |ovary|15/26| |pancreas|19/24| |peripheral nervous system|3/16| |plasma cell|10/15| |prostate|0/1| |skin|18/24| |soft tissue|1/7| |thyroid|2/2| |upper aerodigestive|14/22| |urinary tract|19/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2079 * **Expression level (log2 read counts)**: 7.79 {{:chemogenomics:nalm6 dist.png?nolink |}}